PESAA09	Excess BAFF alters the Breg potential of human marginal zone B-cells in the context of HIV-1 infection	Poster exhibition	Systemic immune activation and inflammation
PESAA10	Cerebrospinal fluid cellular inflammatory gene expression profile in people with acute HIV-1 infection	Poster exhibition	Systemic immune activation and inflammation
PESAA11	A longitudinal assessment of the impact of antiretroviral therapy and HIV-1 associated inflammation on neurocognitive outcomes in perinatally infected (PHIV) children in South Africa	Poster exhibition	Systemic immune activation and inflammation
PESAA12	No evidence that ongoing HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term suppressive ART	Poster exhibition	Systemic immune activation and inflammation
PESAA13	Soluble interferon receptor (sIFNAR2) inhibits HIV-1 infection in macrophages through IFN-Î²-independent pathways	Poster exhibition	Innate immunity (including NK cells)
PESAB01	Successful recruitment of Youth with untreated HIV infection in Adolescent Trials Network 147: early treatment of acute HIV infection	Poster exhibition	Acute and early infection
PESAB02	In-hospital mortality among persons with HIV (PWH) in the US and Canada, 2005-2018	Poster exhibition	Morbidity, mortality and life expectancy in clinical research
PESAB03	High accuracy of an enzyme-linked immunoasssay for detection of tenofovir alafenamide: implications for point-of-care antiretroviral adherence monitoring	Poster exhibition	Adherence testing
PESAB04	Comparison of Advanced HIV Disease identification using CD4 results from a semi-quantitative CD4 point of care test and CD4 flow cytometry in Nigeria	Poster exhibition	Viral load and CD4 monitoring
PESAB05	Circulating mir21 and mir125b in women living with human immunodeficiency virus: utility of biomarkers for monitoring cervical carcinogenesis	Poster exhibition	Diagnostics of co-infections and co-morbidities